BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7622214)

  • 1. Construction and use of integration plasmids to generate site-specific mutations in the Actinomyces viscosus T14V chromosome.
    Yeung MK
    Infect Immun; 1995 Aug; 63(8):2924-30. PubMed ID: 7622214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and function of Actinomyces naeslundii T14V type 1 fimbriae require the expression of additional fimbria-associated genes.
    Yeung MK; Ragsdale PA
    Infect Immun; 1997 Jul; 65(7):2629-39. PubMed ID: 9199430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation of an Actinomyces viscosus T14V type 1 fimbrial subunit homolog among divergent groups of Actinomyces spp.
    Yeung MK
    Infect Immun; 1992 Mar; 60(3):1047-54. PubMed ID: 1347285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and expression of a type 1 fimbrial subunit of Actinomyces viscosus T14V.
    Yeung MK; Chassy BM; Cisar JO
    J Bacteriol; 1987 Apr; 169(4):1678-83. PubMed ID: 2881922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutants of Actinomyces viscosus T14V lacking type 1, type 2, or both types of fimbriae.
    Cisar JO; Vatter AE; Clark WB; Curl SH; Hurst-Calderone S; Sandberg AL
    Infect Immun; 1988 Nov; 56(11):2984-9. PubMed ID: 2902012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical and functional studies of Actinomyces viscosus T14V type 1 fimbriae with monoclonal and polyclonal antibodies directed against the fimbrial subunit.
    Cisar JO; Barsumian EL; Siraganian RP; Clark WB; Yeung MK; Hsu SD; Curl SH; Vatter AE; Sandberg AL
    J Gen Microbiol; 1991 Aug; 137(8):1971-9. PubMed ID: 1683401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strains of Actinomyces naeslundii and Actinomyces viscosus exhibit structurally variant fimbrial subunit proteins and bind to different peptide motifs in salivary proteins.
    Li T; Johansson I; Hay DI; Strömberg N
    Infect Immun; 1999 May; 67(5):2053-9. PubMed ID: 10225854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different type 1 fimbrial genes and tropisms of commensal and potentially pathogenic Actinomyces spp. with different salivary acidic proline-rich protein and statherin ligand specificities.
    Li T; Khah MK; Slavnic S; Johansson I; Strömberg N
    Infect Immun; 2001 Dec; 69(12):7224-33. PubMed ID: 11705891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Actinomyces viscosus antigens in Escherichia coli: cloning of a structural gene (fimA) for type 2 fimbriae.
    Donkersloot JA; Cisar JO; Wax ME; Harr RJ; Chassy BM
    J Bacteriol; 1985 Jun; 162(3):1075-8. PubMed ID: 2860095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
    Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
    Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic control of serum antibody responses of inbred mice to type 1 and type 2 fimbriae from Actinomyces viscosus T14V.
    Haber J; Grinnell CM; Beem JE; Clark WB
    Infect Immun; 1991 Jul; 59(7):2364-9. PubMed ID: 1675628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a gene involved in assembly of Actinomyces naeslundii T14V type 2 fimbriae.
    Yeung MK; Donkersloot JA; Cisar JO; Ragsdale PA
    Infect Immun; 1998 Apr; 66(4):1482-91. PubMed ID: 9529071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence homology between the subunits of two immunologically and functionally distinct types of fimbriae of Actinomyces spp.
    Yeung MK; Cisar JO
    J Bacteriol; 1990 May; 172(5):2462-8. PubMed ID: 1970561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fimbria-specific antibodies in serum and saliva of mice immunized with Actinomyces viscosus T14V fimbriae.
    Crawford PC; Clark WB
    Infect Immun; 1986 Nov; 54(2):507-15. PubMed ID: 2876962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amended description of the genes for synthesis of Actinomyces naeslundii T14V type 1 fimbriae and associated adhesin.
    Chen P; Cisar JO; Hess S; Ho JT; Leung KP
    Infect Immun; 2007 Aug; 75(8):4181-5. PubMed ID: 17485454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomyces naeslundii displays variant fimP and fimA fimbrial subunit genes corresponding to different types of acidic proline-rich protein and beta-linked galactosamine binding specificity.
    Hallberg K; Holm C; Ohman U; Strömberg N
    Infect Immun; 1998 Sep; 66(9):4403-10. PubMed ID: 9712794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of Actinomyces viscosus mutants defective in binding salivary proline-rich proteins.
    Nesbitt WE; Beem JE; Leung KP; Clark WB
    Infect Immun; 1992 Mar; 60(3):1095-100. PubMed ID: 1347286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
    Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
    Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.